Confluent Valuation
Is CFLT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CFLT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CFLT * (MX$555) is trading above our estimate of fair value (MX$352.21)
Significantly Below Fair Value: CFLT * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CFLT *?
Key metric: As CFLT * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is CFLT *'s PS Ratio? | |
|---|---|
| PS Ratio | 11.3x |
| Sales | US$915.61m |
| Market Cap | US$10.34b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 10.5x |
| Enterprise Value/EBITDA | -27x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CFLT *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 9.5x | ||
KVYO Klaviyo | 11.4x | 18.3% | US$9.9b |
PCOR Procore Technologies | 10.3x | 12.1% | US$11.4b |
U Unity Software | 4.8x | 1.4% | US$9.5b |
APPF AppFolio | 11.4x | 16.2% | US$8.7b |
CFLT * Confluent | 11.3x | 16.6% | Mex$10.3b |
Price-To-Sales vs Peers: CFLT * is expensive based on its Price-To-Sales Ratio (11.3x) compared to the peer average (9.5x).
Price to Sales Ratio vs Industry
How does CFLT *'s PS Ratio compare vs other companies in the Global Software Industry?
| 246 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 246 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: CFLT * is expensive based on its Price-To-Sales Ratio (11.3x) compared to the Global Software industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is CFLT *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 11.3x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CFLT *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | Mex$634.22 0% | 11.8% | Mex$804.68 | Mex$502.93 | n/a | 31 |
| Nov ’25 | n/a | Mex$639.25 0% | 11.8% | Mex$811.06 | Mex$506.92 | n/a | 31 |
| Oct ’25 | n/a | Mex$574.53 0% | 14.4% | Mex$776.11 | Mex$446.26 | n/a | 30 |
| Sep ’25 | n/a | Mex$566.29 0% | 13.1% | Mex$747.90 | Mex$448.74 | n/a | 29 |
| Aug ’25 | n/a | Mex$577.51 0% | 12.3% | Mex$750.88 | Mex$469.30 | n/a | 29 |
| Jul ’25 | n/a | Mex$652.53 0% | 10.6% | Mex$776.47 | Mex$517.65 | n/a | 31 |
| Jun ’25 | Mex$513.91 | Mex$588.99 +14.6% | 10.8% | Mex$700.67 | Mex$467.11 | n/a | 30 |
| May ’25 | n/a | Mex$567.85 0% | 12.5% | Mex$702.06 | Mex$451.32 | n/a | 29 |
| Apr ’25 | n/a | Mex$570.56 0% | 12.6% | Mex$703.97 | Mex$452.56 | n/a | 29 |
| Mar ’25 | n/a | Mex$569.68 0% | 15.0% | Mex$716.61 | Mex$328.79 | n/a | 29 |
| Feb ’25 | Mex$370.00 | Mex$452.26 +22.2% | 16.6% | Mex$688.90 | Mex$331.88 | n/a | 28 |
| Jan ’25 | n/a | Mex$428.35 0% | 14.3% | Mex$585.11 | Mex$326.97 | n/a | 25 |
| Dec ’24 | n/a | Mex$422.89 0% | 14.6% | Mex$584.23 | Mex$326.48 | n/a | 25 |
| Nov ’24 | Mex$500.00 | Mex$690.33 +38.1% | 11.2% | Mex$812.41 | Mex$541.61 | n/a | 21 |
| Oct ’24 | n/a | Mex$692.55 0% | 8.7% | Mex$789.98 | Mex$526.66 | n/a | 20 |
| Sep ’24 | n/a | Mex$673.07 0% | 8.6% | Mex$769.11 | Mex$512.74 | n/a | 21 |
| Aug ’24 | n/a | Mex$628.42 0% | 14.4% | Mex$757.83 | Mex$404.18 | n/a | 19 |
| Jul ’24 | n/a | Mex$636.41 0% | 14.8% | Mex$770.72 | Mex$411.05 | n/a | 19 |
| Jun ’24 | n/a | Mex$504.12 0% | 13.6% | Mex$619.09 | Mex$353.77 | Mex$513.91 | 20 |
| May ’24 | n/a | Mex$509.12 0% | 13.2% | Mex$593.34 | Mex$341.62 | n/a | 19 |
| Apr ’24 | Mex$385.62 | Mex$542.24 +40.6% | 26.3% | Mex$1,093.58 | Mex$346.30 | n/a | 20 |
| Mar ’24 | n/a | Mex$555.69 0% | 26.9% | Mex$1,117.26 | Mex$353.80 | n/a | 19 |
| Feb ’24 | Mex$410.08 | Mex$555.69 +35.5% | 26.9% | Mex$1,117.26 | Mex$353.80 | Mex$370.00 | 19 |
| Jan ’24 | Mex$410.08 | Mex$709.50 +73.0% | 25.9% | Mex$1,188.32 | Mex$495.13 | n/a | 17 |
| Dec ’23 | n/a | Mex$710.84 0% | 25.2% | Mex$1,178.96 | Mex$491.23 | n/a | 17 |
| Nov ’23 | n/a | Mex$767.92 0% | 25.0% | Mex$1,281.79 | Mex$591.60 | Mex$500.00 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.